LAURA BEARDEN: Open Payments
NPI 1902552508 · MADISONVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$584 in 36 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $584
Food & beverage: $584
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 10 | $170 |
| Novartis Pharmaceuticals Corporation | 12 | $149 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 7 | $122 |
| Alnylam Pharmaceuticals Inc. | 2 | $48 |
| Boston Scientific Corporation | 1 | $24 |
| ABIOMED | 1 | $20 |
| AstraZeneca Pharmaceuticals LP | 1 | $19 |
| Merck Sharp & Dohme LLC | 1 | $17 |
| Inspire Medical Systems, Inc. | 1 | $14 |
Products named: REPATHA, LEQVIO, LifeVest, ONPATTRO, BodyGuardian, AMVUTTRA, FARXIGA, VERQUVO.
Industry payments across KY — which companies pay providers there.
